These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 6599821

  • 21. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
    Grosfeld H, Barak D, Ordentlich A, Velan B, Shafferman A.
    Mol Pharmacol; 1996 Sep; 50(3):639-49. PubMed ID: 8794905
    [Abstract] [Full Text] [Related]

  • 22. In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.
    Musilova L, Kuca K, Jung YS, Jun D.
    Clin Toxicol (Phila); 2009 Jul; 47(6):545-50. PubMed ID: 19586353
    [Abstract] [Full Text] [Related]

  • 23. Ketamine protects acetylcholinesterase against in vitro inhibition by sarin.
    Puu G.
    Biochem Pharmacol; 1988 Mar 01; 37(5):969-70. PubMed ID: 3345207
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Reactivation and aging kinetics of human acetylcholinesterase inhibited by organophosphonylcholines.
    Worek F, Thiermann H, Szinicz L.
    Arch Toxicol; 2004 Apr 01; 78(4):212-7. PubMed ID: 14647978
    [Abstract] [Full Text] [Related]

  • 30. Comparison of three enzymatic models for evaluation of reactivators of organophosphorus ester inhibited acetylcholinesterase.
    Miller A, Nolen HW, Jackson SE, Howd RA, Harris RN, Bedford CD.
    Proc West Pharmacol Soc; 1984 Apr 01; 27():297-301. PubMed ID: 6494168
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Bisquaternary oximes as reactivators of tabun-inhibited human brain cholinesterases: an in vitro study.
    Kuca K, Jun D, Cabal J, Musilova L.
    Basic Clin Pharmacol Toxicol; 2007 Jul 01; 101(1):25-8. PubMed ID: 17577312
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Reactivation of human brain homogenate cholinesterases inhibited by Tabun using newly developed oximes K117 and K127.
    Kuca K, Cabal J, Jung YS, Musilek K, Soukup O, Jun D, Pohanka M, Musilova L, Karasová J, Novotný L, Hrabinova M.
    Basic Clin Pharmacol Toxicol; 2009 Sep 01; 105(3):207-10. PubMed ID: 19473310
    [Abstract] [Full Text] [Related]

  • 36. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
    Jun D, Musilova L, Kuca K, Kassa J, Bajgar J.
    Chem Biol Interact; 2008 Sep 25; 175(1-3):421-4. PubMed ID: 18617161
    [Abstract] [Full Text] [Related]

  • 37. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon.
    Petroianu GA, Nurulain SM, Nagelkerke N, Shafiullah M, Kassa J, Kuca K.
    J Appl Toxicol; 2007 Sep 25; 27(5):453-7. PubMed ID: 17304644
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.